SCHEMBL4452495

SCHEMBL4452495

CCC1OC(=O)N(C)C1c1ccc(-c2ccccc2)c(F)c1F

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.33
GRM2 Q14416 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4450106 0.84 BRD4 (0.35) BRD4GRM2
SCHEMBL4460820 0.70 TNKS (0.41) BRD4
SCHEMBL4480095 0.68 CTRC (0.35) BRD4GRM2
SCHEMBL4458127 0.65 GRM2 (0.38) GRM2
SCHEMBL4454488 0.64 KDM4E (0.34) BRD4GRM2
SCHEMBL4469790 0.64 PTGDR2 (0.35) GRM2
SCHEMBL4474719 0.63 PDE3B (0.39)
SCHEMBL10533047 0.62 ALOX5AP (0.53)
SCHEMBL4460630 0.62 GRM2 (0.41) GRM2
SCHEMBL4454827 0.61 ESR2 (0.39) BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137577-A1 HETEROCYCLIC COMPOUNDS PFIZER INC. 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137577-A1 HETEROCYCLIC COMPOUNDS CYP2D6, ABCG2, CYP2B6 BRD4 2170/4885GRM2 4432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.